



2008, Vol. 15, No. 6, pp. 555–557
Copyright © 2008 Via Medica
ISSN 1897–5593
Address for correspondence: Murat Turfan, MD, Department of Cardiology, Gazi University School of Medicine, 06500,
Besevler, Ankara, Turkey, tel: +90 312 2025629; fax: +90 312 2129012, e-mail: turphan@gmail.com
Received: 23.07.2008 Accepted: 19.09.2008
Atrial flutter with 1:1 conduction in
a 70-year-old man with hyperthyroidism
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Abstract
Atrial flutter (AFL) is a rapid, regular atrial tachyarrhythmia that occurs most commonly in
patients with underlying structural heart disease. AFL with 1:1 atrioventricular (AV) conduc-
tion is a rare occasion. We describe a 70-year-old male patient with hyperthyroidism in whom
AFL was associated with 1:1 AV conduction. This case report emphasizes that AFL with 1:1
AV conduction should be kept in mind as a diagnostic alternative in patients with rapid
supraventricular tachycardia and hyperthyroidism. (Cardiol J 2008; 15: 555–557)
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Introduction
Atrial flutter (AFL) with 1:1 atrioventricular
(AV) conduction, although a rare occurrence, may
be fatal [1]. It may be associated with class I antiar-
rhythmic drug use, accessory AV pathways, hyper-
thyroidism and exercise [2–5]. We describe a 70-year-
-old male patient with AFL with 1:1 AV conduction
associated with hyperthyroidism.
Case report
A 70-year-old male patient was referred to our
institution because of rapid heart rate. He had been
diagnosed with hyperthyroidism, AFL and wide
QRS tachycardia of unknown etiology 1 month ago
at the referring centre (Fig. 1A). The patient com-
plained of dyspnea and frequent rapid palpitations
associated with shortness of breath for 2–3 years.
He had a history of prior myocardial infarction, he-
art failure and chronic obstructive lung disease. His
current medications included propylthiouracil 50 mg
and propranolol 40 mg per day.
On admission, heart rate was 140 beats per
minute and regular. Blood pressure was 120/80 mm Hg.
There were no S3 or S4 gallops. A grade 1 systolic
murmur was audible at the left lower sternal bor-
der and the apex. Breath sounds were decreased
and expiratory phase was prolonged. A few crackles
were heard at the lung bases.
The initial electrocardiogram showed AFL with
2:1 AV conduction and a ventricular rate of 142 beats
per minute (Fig. 1B). Intravenous diltiazem slowed
AV nodal conduction to 4:1 (Fig. 1C). He was put on
diltiazem 180 mg per day and digoxin 0.25 mg per
day for rate control. Lisinopril 2.5 mg per day, spi-
ronolactone 25 mg per day, enoxaparin 140 mg per
day SC and atorvastatin 40 mg per day were added
to the treatment regimen.
A transthoracic echocardiogram showed global
hypokinesis with an ejection fraction of 0.31. A tran-
sesophageal echocardiogram showed no evi-
dence of left atrial thrombus. The thyroid function
tests revealed a euthyroid state.
On reviewing the previously recorded wide
QRS tachycardia with right bundle branch block
(RBBB) morphology (284 beats per minute), we de-
cided that it was probably due to AFL with 1:1 AV
conduction and right bundle aberrancy. But owing
to the presence of low ejection fraction and a history
of myocardial infarction, we decided to proceed with
electrophysiological study (EPS) to rule out the
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Figure 1. A. Wide QRS tachycardia recorded 1 month before admission; B. Admission ECG showing atrial flutter with
2:1 atrioventricular conduction; C. Follow-up ECG of patient after administration of IV diltiazem; D. ECG after
synchronized cardioversion.
possibility of ventricular tachycardia. During the
EPS, neither a ventricular tachycardia was induced
nor an accessory pathway demonstrated. The AFL
could not be terminated with overdrive atrial pacing,
but a synchronized 50 J shock was successful in
restoring sinus rhythm (Fig. 1D).
The patient was discharged on propylthioura-
cil, aspirin, diltiazem, lisinopril, digoxin, spironolac-
tone and atorvastatin. At 1-year follow-up, the pa-
tient remained in sinus rhythm without the need
for any antiarrhythmics. Moreover, ejection fraction
was found to be improved from 0.31 to 0.45.
Discussion
Atrial flutter is a rapid, regular atrial tachyarr-
hythmia. Its incidence is 88/100,000 person-years
in the general population, and is 2.5 times more
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common in men [6]. The incidence increases with
age. The risk of developing AFL increases 3.5 ti-
mes in subjects with heart failure and 1.9 times in
subjects with chronic obstructive pulmonary dise-
ase [6]. Hyperthyroidism is also a predisposing fac-
tor for AFL. Atrial flutter or fibrillation was repor-
ted to be found in 8.3% of patients within 30 days
of the date of diagnosis of hyperthyroidism [7]. Male
sex, increasing age, ischemic heart disease, conge-
stive heart failure and valvular heart disease are as-
sociated with an increased risk of atrial fibrillation
or flutter in patients with hyperthyroidism [7].
Due to the physiological properties of the AV
node, normally not all of the impulses can reach the
His-Purkinje system, so that ventricular rate is lo-
wer than the atrial rate during atrial flutter and
fibrillation [8]. The most common AV conduction ra-
tio in patients with untreated AFL is 2:1, which pro-
duces the typical ventricular rate of 150 beats per
minute. Although very rare, life threatening 1:1 AV
conduction during AFL may also be seen [1]. Class I
antiarrhythmic drugs may slow the atrial rate, thus
increasing the likelihood of 1:1 A:V conduction du-
ring AFL especially in patients with rapid AV nodal
conduction [2]. In patients with accessory AV pa-
thways, impulses may be conducted from the atrium
to the ventricle without delay in the AV node [3].
Hyperthyroidism may enhance AV conduction, so
it may result in 1:1 AV conduction during AFL [4].
Even in the absence of the aforementioned factors,
exercise per se may cause 1:1 AV conduction due
to both increased flutter cycle length and enhanced
AV conduction [5].
In our case, to elucidate the mechanism of wide
QRS tachycardia, EPS was performed. However,
during the study neither a wide QRS tachycardia
could be induced nor an accessory pathway demon-
strated. Also in the hospitalization period no wide
QRS tachycardia could be observed. Nevertheless,
since the wide QRS tachycardia rate was exactly the
same with the admission AFL rate, definite diagno-
sis was thought to be AFL with 1:1 AV conduction
and RBBB aberrancy.
The patient was observed for 1 year. There
were no further recurrences of AFL or wide QRS
tachycardia during this period. The left ventricular
ejection fraction improved from 0.31 to 0.45 imply-
ing that AFL with rapid ventricular response mi-
ght have played a role in the initial low ejection frac-
tion. Luchsinger and Steinberg [9] showed that re-
storation of normal sinus rhythm by ablation in
patients with chronic AFL and cardiomyopathy sub-
stantially improves left ventricular function.
In summary, when wide QRS tachycardia with
a rate of about 300 beats per minute is encounte-
red in a patient, the clinician should be alert to the
possibility of AFL with 1:1 AV conduction and hy-
perthyroidism.
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